Company news

Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290) news

Kwang Dong Pharmaceutical Co., Ltd. news releases on 6ix. Latest, Nov 5, 2025: Ocugen Provides Business Update with Third Quarter 2025 Financial Results

View Kwang Dong Pharmaceutical Co., Ltd. →

Press releases & updates

Ocugen Provides Business Update with Third Quarter 2025 Financial Results

November 5, 2025

Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea

September 15, 2025